CAS: 2143096-93-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Navitoclax-piperazine REF: TM-T12186CAS: 2143096-93-7 | 99.11% - 99.82% | 156.00 €~1,529.00 € | Wed 26 Mar 25 |
 | Navitoclax-piperazine REF: 3D-TKD09693CAS: 2143096-93-7 | Min. 95% | 324.00 €~4,080.00 € | Wed 07 May 25 |
Navitoclax-piperazine
CAS:2143096-93-7
Navitoclax-piperazine (ABT-263-piperazine) is an inhibitor of B-cell lymphoma extra large (BCL-XL).
Formula:
C47H56ClF3N6O5S3
Purity:
99.11% - 99.82%
Color and Shape:
Solid
Molecular weight:
973.63
Ref: TM-T12186
| 1mg | 156.00 € | ||
| 5mg | 308.00 € | ||
| 10mg | 522.00 € | ||
| 25mg | 825.00 € | ||
| 50mg | 1,130.00 € | ||
| 100mg | 1,529.00 € | ||
| 1mL*10mM (DMSO) | 532.00 € |
Estimated delivery in United States, on Wednesday 26 Mar 2025
Navitoclax-piperazine
CAS:2143096-93-7
Navitoclax-piperazine is a cell biology research tool that inhibits protein interactions. It is a small …
Formula:
C47H56ClF3N6O5S3
Purity:
Min. 95%
Molecular weight:
973.6 g/mol
Ref: 3D-TKD09693
| 2mg | 831.00 € | ||
| 5mg | 1,252.00 € | ||
| 10mg | 1,700.00 € | ||
| 25mg | 2,720.00 € | ||
| 50mg | 4,080.00 € |
Estimated delivery in United States, on Wednesday 7 May 2025
